Latin America Infusion Therapy Devices Market Size, Share and Forecast 2032

Latin America Infusion Therapy Devices Market Overview:

The Latin America Infusion Therapy Devices Market size was valued at USD 1,704.07 MN in 2021 and reached USD 2,257.37 MN in 2025. It is anticipated to reach USD 3,852.87 MN by 2032, growing at a CAGR of 6.67% during the forecast period.

Latin America Infusion Therapy Devices Market Insights

• Market growth is supported by cancer therapy demand, diabetes management, biologics administration, hospital infusion safety, ambulatory care expansion and homecare-based infusion models.
• Large Volume Pumps hold a strong position because hospitals and clinics use them for IV fluids, chemotherapy, parenteral nutrition, antibiotics, pain management and critical care infusion.
• Portable Infusion Pumps are gaining momentum due to homecare, ambulatory chemotherapy, chronic therapy, diabetes care and outpatient infusion models.
• Hospitals And Clinics remain the leading end-user segment because infusion therapy requires clinical oversight, medication safety protocols, trained nurses, pump programming and monitoring.

Latin America Infusion Therapy Devices Market Segment Insights

By product type

By product type, Large Volume Pumps held a strong position in 2025 because hospitals and clinics depend on them for high-volume medication delivery, IV fluids, antibiotics, chemotherapy, parenteral nutrition, anesthesia support and critical care. Syringe Infusion Pumps remain important in neonatal care, intensive care, anesthesia, oncology and specialty drug administration where precise low-volume delivery is required. Elastomeric Pumps are gaining relevance in ambulatory chemotherapy, postoperative analgesia and home infusion because they are portable and mechanically simple. Others include ambulatory pumps, enteral pumps, specialty infusion accessories and pump-related software platforms. Demand will depend on drug administration complexity, patient safety, maintenance, reimbursement and hospital procurement.

By mobility

By mobility, Stationary Infusion Pumps held the strongest position in 2025 because hospital wards, ICUs, operating rooms, oncology departments and emergency units require stable, programmable and connected infusion systems. Portable Infusion Pumps are expected to grow faster as treatment shifts toward outpatient and homecare settings. Portable devices support chemotherapy, pain management, diabetes, antibiotics, biologics and selected chronic therapies outside inpatient facilities. Mobility demand will depend on battery life, programming safety, alarm systems, patient training, ambulatory workflow compatibility and availability of consumables. Hospitals will continue to use both stationary and portable systems depending on procedure type and care setting.

By application

By application, Cancer held a strong position in 2025 because chemotherapy, immunotherapy support, pain management and supportive care often require infusion pumps and controlled drug delivery. Diabetes supports demand for insulin infusion and portable systems, while Multiple Sclerosis and Rheumatoid Arthritis support infusion therapy through biologics and specialty medicines administered in clinics or homecare settings. Others include antibiotics, pain management, nutrition, hydration, anesthesia and critical care medication delivery. Application growth will be shaped by chronic disease burden, drug pipeline evolution, specialty clinic networks, reimbursement and clinician comfort with home-based infusion.

By end-user

By end-user, Hospitals And Clinics held the strongest position in 2025 because most infusion therapies require medication preparation, nurse supervision, pump programming, adverse event management and clinical documentation. Ambulatory Surgical Centers generate demand for perioperative fluids, anesthesia, pain management and recovery support. Homecare is expanding as payers and providers shift selected therapies outside hospitals to reduce inpatient burden and improve patient convenience. Others include oncology centers, specialty infusion centers, long-term care facilities and emergency providers. Growth will depend on training, device reliability, medication safety, patient selection and home infusion service capacity.

Key Market Drivers

Cancer treatment and chemotherapy infusion demand

Cancer treatment and chemotherapy infusion demand represent major growth drivers for the Latin America Infusion Therapy Devices Market. Latin America and the Caribbean recorded 1,551,060 new cancer cases and 749,242 cancer deaths in 2022, creating sustained demand for oncology infusion, supportive care and pain management pathways. Infusion therapy devices support chemotherapy, hydration, antiemetics, antibiotics, analgesics and supportive drug administration across hospitals, clinics, ambulatory infusion centers and selected homecare programs. This driver supports Large Volume Pumps, Syringe Infusion Pumps, Portable Infusion Pumps, Hospitals And Clinics and Cancer applications.

Diabetes burden and insulin delivery needs

Diabetes burden and insulin delivery needs strengthen demand for infusion and controlled drug delivery systems. PAHO reported that 112 million adults in the Region of the Americas lived with diabetes in 2022, equal to an age-standardized prevalence of 13.1%. Diabetes care supports demand for portable infusion pumps, insulin delivery support, homecare training and chronic disease management technologies. Infusion devices are also relevant for hospitalized diabetic patients who require precise insulin administration during surgery, critical care or acute illness. This driver supports Portable Infusion Pumps, Syringe Infusion Pumps, Homecare, Hospitals And Clinics and Diabetes applications.

Medication safety and smart infusion pump adoption

Medication safety and smart infusion pump adoption are supporting replacement demand because infusion errors can create avoidable patient harm. WHO states that unsafe medication practices and medication errors are a leading cause of injury and avoidable harm in health care systems worldwide, with medication error costs estimated at USD 42 billion annually. Infusion therapy devices with dose-error reduction, alarms, drug libraries, connectivity and workflow integration can reduce administration risk in hospitals and clinics. This driver supports Large Volume Pumps, Syringe Infusion Pumps, Stationary Infusion Pumps, Hospitals And Clinics and Ambulatory Surgical Centers.

Infusion and nutrition systems investment by global suppliers

Infusion and nutrition systems investment by global suppliers supports product availability and clinical adoption across Latin America. Fresenius said its 2025 organic growth benefited from development in Europe, Latin America and the United States, while Fresenius Kabi increased EBIT by 7% to EUR 1,413 million. Fresenius also described its MedTech Infusion and Nutrition Systems portfolio as including infusion and nutrition pumps, dedicated disposables and software-based solutions focused on application safety, therapy efficiency and interoperability with hospital systems. This driver supports Syringe Infusion Pumps, Large Volume Pumps, Portable Infusion Pumps, Stationary Infusion Pumps and hospital modernization.

Growth in connected infusion and medication management systems

Growth in connected infusion and medication management systems is improving infusion therapy safety and workflow efficiency. BD reported fiscal 2025 Medication Delivery Solutions revenue of USD 4.575 billion and referenced Medication Management Solutions strength in infusion systems and higher utilization of infusion sets. ICU Medical said it develops and sells medical products used in infusion therapy, vascular access and vital care applications, with revenue reported by product line in its 2025 annual filing. This driver supports Large Volume Pumps, Syringe Infusion Pumps, Hospitals And Clinics, Ambulatory Surgical Centers and medication management platforms.

Key Trends and Opportunities

Portable infusion expands homecare and ambulatory treatment

Portable infusion is expanding homecare and ambulatory treatment because oncology, pain management, antibiotics, diabetes and specialty therapies increasingly require flexible drug delivery outside inpatient settings. PAHO reported in 2026 that 14.4% of people aged 65 and older in Latin America and the Caribbean, or about 8 million people, require long-term care, with the share projected to rise to 16% by 2050. This trend supports Portable Infusion Pumps, Elastomeric Pumps, Homecare and chronic therapy applications. Adoption will depend on patient training, nurse follow-up, pump reliability, payer coverage and consumable supply.

Elastomeric pumps gain use in outpatient infusion

Elastomeric pumps are gaining use in outpatient infusion because they offer a portable option for selected chemotherapy, pain management and antibiotic therapies. These devices can reduce facility time when patients are clinically appropriate for ambulatory treatment. Latin America’s growing oncology burden and long-term care needs support demand for simpler portable delivery systems in hospitals, clinics and homecare programs. Growth will depend on medication compatibility, flow accuracy, clinician acceptance, infection control, reimbursement and distributor availability.

Interoperability becomes a purchase criterion

Interoperability is becoming a purchase criterion as hospitals seek infusion devices that connect with medication management platforms, drug libraries, electronic health records and clinical monitoring systems. Fresenius Kabi’s Infusion and Nutrition Systems portfolio includes software-based solutions focused on application safety, user workflows, therapy efficiency and interoperability with hospital systems. This trend supports Stationary Infusion Pumps, Large Volume Pumps, Hospitals And Clinics and Ambulatory Surgical Centers. Suppliers with integrated software, cybersecurity controls, service support and training will gain stronger procurement advantage.

Specialty biologics support infusion center growth

Specialty biologics support infusion center growth because Multiple Sclerosis, Rheumatoid Arthritis, Cancer and other chronic diseases require periodic administration in controlled settings. PAHO reported that NCD deaths in the Americas reached 6 million in 2021, with cardiovascular diseases, cancer, diabetes and chronic respiratory conditions forming the largest burden. Specialty clinics and ambulatory infusion centers can help manage recurring therapies while reducing hospital crowding. This trend supports Large Volume Pumps, Syringe Infusion Pumps, Stationary Infusion Pumps, Portable Infusion Pumps and Specialty infusion end users included under Hospitals And Clinics and Others.

Key Market Challenges

High equipment cost and budget pressure

High equipment cost and budget pressure remain major challenges for the Latin America Infusion Therapy Devices Market. Smart infusion pumps, syringe pumps, large volume pumps and connected systems require capital spending, maintenance, software updates, drug library management and staff training. Public hospitals often face procurement delays and budget constraints, while private clinics must justify investment through patient volume and payer coverage. Cost pressure can also slow replacement cycles and limit adoption of advanced safety features. Vendors must offer financing, managed service models and value-tier systems to improve adoption.

Training and medication safety workflow burden

Training and medication safety workflow burden can limit effective pump utilization. Infusion therapy requires accurate dose programming, line management, alarm response, drug library updates, patient monitoring and documentation. WHO’s Medication Without Harm initiative highlights medication errors as a major global safety issue, reinforcing the need for safer medication systems and practices. Hospitals must train nurses, pharmacists, biomedical engineers and physicians to use connected pumps correctly. Suppliers that provide clinical education, software support and protocol integration will improve device adoption.

Consumable availability and maintenance risk

Consumable availability and maintenance risk can disrupt infusion therapy. Pumps require administration sets, tubing, syringes, connectors, elastomeric reservoirs, batteries, spare parts and software support. Supply interruption can delay chemotherapy, antibiotics, nutrition and pain management. Latin America’s imported device dependence, currency volatility and distributor fragmentation can increase availability risk. Vendors with regional warehousing, preventive maintenance programs, local engineers and reliable consumable supply will be better positioned.

Regulatory and product recall pressure

Regulatory and product recall pressure affects infusion pump adoption because these devices are safety-critical and require strong quality controls. Baxter’s 2025 annual filing referenced voluntary correction activity for Novum LVP due to potential under-infusion when the pump remained in standby mode for an extended period. Such issues can increase hospital scrutiny around device safety, software updates, alarms and post-market support. Manufacturers must maintain strong quality systems, timely field actions, clear training materials and responsive regulatory communication.

Regional Analysis

Brazil

Brazil leads the Latin America Infusion Therapy Devices Market due to its large hospital network, oncology demand, chronic disease burden and established private health care sector. Hospitals And Clinics remain the leading end users, while Homecare and ambulatory infusion models are gaining relevance. Large Volume Pumps, Syringe Infusion Pumps and Stationary Infusion Pumps remain core hospital categories. Portable Infusion Pumps and Elastomeric Pumps will gain demand in oncology, antibiotics and pain management. Growth will depend on public procurement, private hospital investment, regulatory approvals, clinical training and local distributor strength.

Mexico

Mexico represents a major growth market supported by private hospital networks, cancer care demand, diabetes burden and proximity to North American medical technology supply chains. Hospitals And Clinics dominate demand, while Ambulatory Surgical Centers and Homecare are expanding gradually. Cancer, Diabetes and Others applications support infusion therapy use across oncology, chronic disease care, surgery and emergency treatment. Growth will depend on reimbursement, product availability, hospital budgets, distributor service capability and adoption of safer infusion systems.

Argentina

Argentina offers steady demand for infusion therapy devices through hospitals, oncology clinics, chronic disease management and specialty infusion services. Large Volume Pumps and Syringe Infusion Pumps remain important in public and private hospitals. Portable Infusion Pumps and Elastomeric Pumps will gain selective demand where ambulatory chemotherapy and homecare programs are available. Macroeconomic pressure, currency volatility and import dependency may affect procurement and replacement cycles. Growth will depend on funding stability, device service networks, affordability and clinical evidence.

Colombia

Colombia is an expanding market supported by public-private health care participation, specialty clinics and growing demand for oncology and chronic disease treatment. Hospitals And Clinics generate the largest infusion device demand, while Homecare has long-term opportunity as health systems manage older adults and chronic therapy patients outside inpatient settings. Portable Infusion Pumps and Elastomeric Pumps can support outpatient care. Growth will depend on payer coverage, care coordination, clinical training, consumable availability and regulatory access.

Chile

Chile represents a relatively mature market in the region due to structured health care access, private hospital activity and chronic disease management. Infusion therapy devices are used across oncology, surgery, pain management, critical care, diabetes and specialty drug administration. Hospitals And Clinics remain the main end users, while Ambulatory Surgical Centers and Homecare offer growth potential. Adoption of connected infusion platforms will depend on procurement policy, medication safety programs, hospital digitalization and supplier support.

Rest of Latin America

Rest of Latin America includes markets with varied hospital infrastructure, reimbursement, homecare access and specialty infusion capacity. Countries with larger private hospital networks will adopt connected and portable infusion devices faster, while lower-resource markets will prioritize essential pumps, consumables and basic infusion safety. PAHO’s NCD data for the Americas shows a sustained chronic disease burden that will continue to drive drug administration and long-term care needs. Growth will depend on distributor reach, product affordability, public procurement and nurse training.

Report Attribute Details

Latin America Infusion Therapy Devices Market Segmentations

By Product Type

• Syringe Infusion Pumps
• Large Volume Pumps
• Elastomeric Pumps
• Others

By Mobility

• Portable Infusion Pumps
• Stationary Infusion Pumps

By Application

• Multiple Sclerosis
• Diabetes
• Rheumatoid Arthritis
• Cancer
• Others

By End-User

• Hospitals And Clinics
• Ambulatory Surgical Centers
• Homecare
• Others

Key Players

• Mindray
• Fresenius Kabi AG
• Ossila
• Ace-medical
• ICU Medical
• Chmyx Inc.
• Baxter
• Becton, Dickinson and Company
• Micrel Medical Devices SA
• AKAS Infusions
• Narang Medical Limited
• Monidor Oy
• Smiths Group plc
• B. Braun SE
• Trivitron Healthcare
• Eitan Medical

Recent Developments

• In 2025, Fresenius reported that Fresenius Kabi revenue reached EUR 8,612 million and that organic growth benefited from good development in Europe, Latin America and the United States.
• In 2025, Fresenius said its MedTech business advanced infusion therapy with the rollout of the Ivenix Infusion System.
• In fiscal 2025, BD reported Medication Delivery Solutions revenue of USD 4.575 billion and continued activity across medication delivery and medication management platforms.
• In 2025, Baxter reported that its Medical Products & Therapies segment included sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical products.
• In fiscal 2025, B. Braun commissioned the highly automated ACTIVE plant for infusion therapy single-use products in Melsungen.

Report Coverage

The research report offers an in-depth analysis based on product type, mobility, application, end-user and geography. It details leading market players, providing an overview of their business positioning, infusion therapy device portfolios, syringe infusion pumps, large volume pumps, elastomeric pumps, portable infusion systems, stationary infusion platforms, software-enabled infusion safety features, administration sets, consumables and strategic relevance in the Latin America Infusion Therapy Devices Market. The report includes insights into the competitive environment, market trends, growth drivers, restraints and opportunities. It also examines cancer treatment demand, diabetes care, biologics administration, medication safety, ambulatory infusion, homecare adoption, pump interoperability, equipment maintenance and regulatory scrutiny as major factors shaping market development. The report assesses the impact of high equipment cost, reimbursement limits, staff training needs, consumable supply risk, product recall pressure and service limitations on market growth. It provides strategic recommendations for infusion device manufacturers, hospitals, clinics, ambulatory surgical centers, homecare providers, distributors, payers, investors and new entrants seeking to navigate Latin America’s infusion therapy device ecosystem.

Future Outlook

• Demand for infusion therapy devices will continue to rise as Latin America expands cancer treatment, chronic disease care and outpatient infusion services.
• Large Volume Pumps will remain a major product category due to high use in hospitals, clinics, oncology departments and critical care settings.
• Syringe Infusion Pumps will gain demand in neonatal care, anesthesia, ICU care and precise specialty drug administration.
• Elastomeric Pumps will expand through ambulatory chemotherapy, postoperative analgesia, antibiotics and homecare-based infusion.
• Portable Infusion Pumps will grow faster as providers shift selected therapies from hospitals to outpatient and homecare settings.
• Stationary Infusion Pumps will remain essential in hospitals, operating rooms, ICUs and oncology units.
• Cancer will remain a leading application due to chemotherapy, supportive care and pain management needs.
• Diabetes will support demand for controlled insulin delivery and hospital-based acute insulin management.
• Hospitals And Clinics will remain the leading end-user segment due to clinical oversight, nurse supervision and medication safety requirements.
• Competition will increase as companies compete on pump safety, interoperability, drug libraries, service uptime, consumable availability, pricing and training support.